No effect of added sugar consumed at median American intake level on glucose tolerance or insulin resistance

Nutrients

Volumn 7, Issue 10, 2015, Pages 8830-8845

  Lowndes, Joshua ^a   Sinnett, Stephanie S ^a   Rippe, James M ^a,b,c  

^a Rippe Lifestyle Institute   (United States)

^b Rippe Lifestyle Institute   (United States)

^c UNIVERSITY OF CENTRAL FLORIDA   (United States)

Author keywords

Diabetes; Fructose; Glucose; High fructose corn syrup; Sucrose

Indexed keywords

FRUCTOSE; GLUCOSE; INSULIN; SUCROSE; GLUCOSE BLOOD LEVEL; SWEETENING AGENT;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY WEIGHT; CALORIC INTAKE; CONTROLLED STUDY; FEMALE; GLUCOSE TOLERANCE; HUMAN; INSULIN RESISTANCE; LOW FAT DIET; MALE; MILK; NUTRITIONAL ASSESSMENT; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PHYSICAL ACTIVITY; PROSPECTIVE STUDY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SUGAR INTAKE; WAIST CIRCUMFERENCE; BLOOD; DIET RESTRICTION; FEEDING BEHAVIOR; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; WEIGHT GAIN; YOUNG ADULT;

ADULT; BLOOD GLUCOSE; FASTING; FEEDING BEHAVIOR; FEMALE; FRUCTOSE; GLUCOSE; GLUCOSE INTOLERANCE; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; SWEETENING AGENTS; WEIGHT GAIN; YOUNG ADULT;

EID: 84945422873     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu7105430     Document Type: Article

References (52)

1. Hu, F.B. Globalization of diabetes: The role of diet, lifestyle, and genes. Diabetes Care 2011, 34, 1249-1257. [CrossRef] [PubMed]
2. Shaw, J.E.; Sicree, R.A.; Zimmet, P.Z. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res. Clin. Pract. 2010, 87, 4-14. [CrossRef] [PubMed]
3. Danaei, G.; Finucane, M.M.; Lu, Y.; Singh, G.M.; Cowan, M.J.; Paciorek, C.J.; Lin, J.K.; Farzadfar, F.; Khang, Y.H.; Stevens, G.A. et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: Systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 2011, 378, 31-40. [CrossRef]
4. International Diabetes Federation. Epidemiology and Morbidity. IDF Diabetes Atlas, Available online: https://www.idf.org/sites/default/files/IDF-Diabetes-Atlas-4th-edition.pdf (accessed on 8 April 2015).
5. De Koning, L.; Malik, V.S.; Kellogg, M.D.; Rimm, E.B.; Willett, W.C.; Hu, F.B. Sweetened beverage consumption, incident coronary heart disease and biomarkers of risk in men. Circulation 2012, 125, 1735-1741. [CrossRef] [PubMed]
6. Montonen, J.; Jarvinen, R.; Knekt, P.; Heliovaara, M.; Reunanen, A. Consumption of sweetened beverages and intakes of fructose and glucose predict type 2 diabetes occurrence. J. Nutr. 2007, 137, 1447-1454.[PubMed]
7. Le, K.A.; Ith, M.; Kreis, R.; Faeh, D.; Bortolotti, M.; Tran, C.; Boesch, C.; Tappy, L. Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes. Am. J. Clin. Nutr. 2009, 89, 1760-1765. [CrossRef] [PubMed]
8. Schulze, M.B.; Hoffmann, K.; Manson, J.E.; Willett, W.C.; Meigs, J.B.; Weikert, C.; Heidemann, C.; Colditz, G.A.; Hu, F.B. Dietary pattern, inflammation, and incidence of type 2 diabetes in women. Am. J. Clin. Nutr. 2005, 82, 675-684. [PubMed]
9. Goran, M.I.; Ulijaszek, S.J.; Ventura, E.E. High fructose corn syrup and diabetes prevalence: A global perspective. Global Public Health 2013, 8, 55-64. [CrossRef] [PubMed]
10. Basu, S.; Yoffe, P.; Hills, N.; Lustig, R.H. The relationship of sugar to population-level diabetes prevalence: An econometric analysis of repeated cross-sectional data. PLoS ONE 2013, 8, 57873. [CrossRef] [PubMed]
11. Bray, G.A. Fructose and risk of cardiometabolic disease. Curr. Atheroscler. Rep. 2012, 14, 570-578. [CrossRef] [PubMed]
12. Johnson, R.; Segal, M.; Sautin, Y.; Nakagawa, T.; Feig, D.I.; Kang, D.H.; Gersch, M.S.; Benner, S.; Sanchez-Lozada, L.G. Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. Am. J. Clin. Nutr. 2007, 86, 899-906. [PubMed]
13. Sanchez-Lozada, L.G.; Le, M.; Segal, M.; Johnson, R.J. How safe is fructose for persons with or without diabetes? Am. J. Clin. Nutr. 2008, 88, 1189-1190. [PubMed]
14. The InterAct Consortium. Consumption of sweet beverages and type 2 diabetes incidence in European adults: Results from EPIC-InterAct. Diabetologia 2013, 56, 1520-1530.
15. Sluijs, I.; Beulens, J.W.J.; van der Schouw, Y.T.; Van der A D.L.; Buckland, G.; Kuijsten, A.; Schulze, M.B.; Amiano, P.; Ardanaz, E.; Balkau, B. Dietary glycemic index, glycemic load, and digestible carbohydrate intake are not associated with risk of type 2 diabetes in eight European countries. J. Nutr. 2013, 143, 93-99.[CrossRef] [PubMed]
16. Pooranaperundevi, M.; Sumiyabanu, M.S.; Viswanathan, P.; Sundarapandiyan, R.; Anuradha, C.V. Insulin resistance induced by high-fructose diet potentiates carbon tetrachloride hepatotoxicity. Toxicol. Ind. Health 2010, 26, 89-104. [CrossRef] [PubMed]
17. Lewis, G.F.; Uffelman, K.; Naples, M.; Szeto, L.; Haidari, M.; Adeli, K. Intestinal lipoprotein overproduction, a nearly recognized component of insulin resistance, is ameliorated by the insulin sensitizer rosiglitazone: Studies in the fructose-fed Syrian golden hamster. Endocrinology 2005, 146, 247-255. [CrossRef] [PubMed]
18. Thorburn, A.W.; Storlien, L.H.; Jenkins, A.B.; Khouri, S.; Kraegen, E.W. Fructose-induced in vivo insulin resistance and elevated plasma triglyceride levels in rats. Am. J. Clin. Nutr. 1989, 49, 1155-1163. [PubMed]
19. Rizkalla, S.W.; Boillot, J.; Tricottet, V.; Fontvieille, A.M.; Luo, J.; Salzman, J.L.; Camilleri, J.P.; Slama, G. Effects of chronic dietary fructose with and without copper supplementation on glycaemic control, adiposity, insulin binding to adipocytes and glomerular basement membrane thickness in normal rats. Br. J. Nutr. 1993, 70, 199-209. [CrossRef] [PubMed]
20. Maiztegui, B.; Borelli, M.I.; Raschia, M.A.; Del Zotto, H.; Gagliardino, J.J. Islet adaptive changes to fructose-induced insulin resistance: Beta-cell mass, glucokinase, glucose metabolism, and insulin secretion. J. Endocrinol. 2009, 200, 139-149. [CrossRef] [PubMed]
21. Mielke, J.G.; Taghibiglou, C.; Liu, L.; Zhang, Y.; Jia, Z.; Adeli, K.; Wang, Y.T. A biochemical and functional characterization of diet-induced brain insulin resistance. J. Neurochem. 2005, 93, 1568-1578. [CrossRef] [PubMed]
22. Stanhope, K.L.; Schwarz, J.M.; Keim, N.L.; Griffen, S.C.; Bremer, A.A.; Graham, J.L.; Hatcher, B.; Cox, C.L.; Dyachenko, A.; Zhang, W. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J. Clin. Investig. 2009, 119, 1322-1334. [CrossRef] [PubMed]
23. Cozma, A.I.; Ha, V.; de Souza, R.J.; Sievenpiper, J. Sweeteners and Diabetes. In Fructose, High Fructose Corn Syrup, Sucrose and Health; Rippe, J.M., Ed.; Springer Publishing: New York, NY, USA, 2014.
24. Saris, W.H.; Astrup, A.; Prentice, A.M.; Zunft, H.J.; Formiguera, X.; Verboeket-vande Venne, W.P.; Raben, A.; Poppitt, S.D.; Seppelt, B.; Johnston, S.; et al. Randomized controlled trial of changes in dietary carbohydrate/fat ratio and simple vs. complex carbohydrates on body weight and blood lipids: The CARMEN study. The Carbohydrate Ratio Management in European National diets. Int. J. Obes. Relat. Metab. Disord. 2000, 24, 1310-1318. [CrossRef] [PubMed]
25. Cozma, A.I.; Sievenpiper, J.L.; de Souza, R.J.; Chiavaroli, L.; Ha, V.; Wang, D.D.; Mirrahimi, A.; Yu, M.E.; Carleton, A.J.; Di Buono; et al. Effect of fructose on glycemic control in diabetes: A systematic review and meta-analysis of controlled feeding trials. Diabetes Care 2012, 35, 1611-1620. [CrossRef] [PubMed]
26. Colditz, G.A.; Manson, J.E.; Stampfer, M.J.; Rosner, B.; Willett, W.C.; Speizer, F.E. Diet and risk of clinical diabetes in women. Am. J. Clin. Nutr. 1992, 55, 1018-1023. [PubMed]
27. Meyer, K.A.; Kushi, L.H.; Jacobs, D.R., Jr.; Slavin, J.; Sellers, T.A.; Folsom, A.R. Carbohydrates, dietary fiber, and incident type 2 diabetes in older women. Am. J. Clin. Nutr. 2000, 71, 921-930. [PubMed]
28. Janket, S.J.; Manson, J.E.; Sesso, H.; Buring, J.E.; Liu, S. A prospective study of sugar intake and risk of type 2 diabetes in women. Diabetes Care 2003, 26, 1008-1105. [CrossRef] [PubMed]
29. Hodge, A.M.; English, D.R.; O’Dea, K.; Giles, G.G. Glycemic index and dietary fiber and the risk of type 2 diabetes. Diabetes Care 2004, 27, 2701-2706. [CrossRef] [PubMed]
30. Morino, K.; Petersen, K.F.; Shulman, G.I. Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction. Diabetes 2006, 55, S9-S15. [CrossRef] [PubMed]
31. Seppala-Lindroos, A.; Vehkavaara, S.; Hakkinen, A.M.; Goto, T.; Westerbacka, J.; Sovijarvi, A.; Halavaara, J.; Yki-Jarvinen, H. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J. Clin. Endocrinol. Metab. 2002, 87, 3023-3028. [CrossRef] [PubMed]
32. Hellerstein, M.K.; Schwarz, J.M.; Neese, R.A. Regulation of hepatic de novo lipogenesis in humans. Annu. Rev. Nutr. 1996, 16, 523-557. [CrossRef] [PubMed]
33. Hellerstein, M.K. No common energy currency: De novo lipogenesis as the road less traveled. Am. J. Clin. Nutr. 2001, 74, 707-708. [PubMed]
34. Peterson, K.F.; Shulman, G.I. Etiology of insulin resistance. Am. J. Med. 2007, 119, 10-16. [CrossRef] [PubMed]
35. Shulman, G.I. Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. N. Engl. J. Med. 2014, 371, 1131-1141. [CrossRef] [PubMed]
36. Lowndes, J.; Kawiecki, D.; Yu, Z.; Rippe, J.M. No Dose Response Relationship in the Effects of Commonly Consumed Sugars on Risk Factors for Diabetes across a Range of Typical Human Consumption Levels. Food Nutr. Sci. 2015, 6, 101-111. [CrossRef]
37. Mifflin, M.D.; Jeor, S.T.; Hill, L.A.; Scott, B.J.; Daugherty, S.A.; Koh, Y.O. A new predictive equation for resting energy expenditure in healthy individuals. Am. J. Clin. Nutr. 1990, 51, 241-247. [PubMed]
38. Matthews, D.R.; Hosker, J.P.; Rudenski, A.S.; Naylor, B.A.; Treacher, D.F.; Turner, R.C. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28, 412-419. [CrossRef] [PubMed]
39. Abdul-Ghani, M.A.; Matsuda, M.; Balas, B.; DeFronzo, R.A. Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test. Diabetes Care 2007, 30, 89-94. [CrossRef] [PubMed]
40. Matsuda, M.; DeFronzo, R.A. Insulin sensitivity indices obtained from oral glucose tolerance testing: Comparison with the euglycemic insulin clamp. Diabetes Care 1999, 22, 1462-1470. [CrossRef] [PubMed]
41. Johnston, R.D.; Stephenson, M.C.; Crossland, H.; Cordon, S.M.; Palcidi, E.; Cox, E.F.; Taylor, M.A.; Aithal, G.P.; MacDonald, I.A. No difference between high fructose and high glucose diets on liver tricylglycerol or biochemistry in healthy overweight men. Gastroenterology 2013, 145, 1016-1025. [CrossRef] [PubMed]
42. Lê, K.-A.; Faeh, D.; Stettler, R.; Ith, M.; Kreis, R.; Vermathen, P.; Boesch, C.; Ravussin, E.; Tappy, L. A 4-wk high-fructose diet alters lipid metabolism without affecting insulin sensitivity or ectopic lipids in healthy humans. Am. J. Clin. Nutr. 2006, 84, 1374-1379. [PubMed]
43. Latulippe, M.E.; Skoog, S.M. Fructose malabsorption and intolerance: Effects of fructose with and without simultaneous glucose ingestion. Crit. Rev. Food Sci. Nutr. 2011, 51, 583-592. [CrossRef] [PubMed]
44. Tappy, L.; Egli, L.; Tran, C. Metabolism of Nutritive Sweeteners in Humans. In Fructose, High Fructose Corn Syrup, Sucrose and Health; Rippe, J.M., Ed.; Springer Publishing: New York, NY, USA, 2014.
45. Silbernagel, G.; Machann, J.; Unmuth, S.; Schick, F.; Stefan, N.; Hans, U.; Ring, H.; Fritsche, A. Effects of 4-week very-high-fructose/glucose diets on insulin sensitivity, visceral fat and intrahepatic lipids: An exploratory trial. Br. J. Nutr. 2011, 106, 79-86. [CrossRef] [PubMed]
46. Pan, A.; Sun, Q.; Bernstein, A.M.; Schulze, M.B.; Manson, J.E.; Willett, W.C.; Hu, F.B. Red meat consumption and risk of type 2 diabetes: 3 Cohorts of US adults and an updated meta-analysis. Am. J. Clin. Nutr. 2011, 94, 1088-1096. [CrossRef] [PubMed]
47. Halton, T.L.; Willett, W.C.; Liu, S.; Manson, J.E.; Stampfer, M.J.; Hu, F.B. Potato and French fry consumption and risk of type 2 diabetes in women. Am. J. Clin. Nutr. 2006, 83, 284-290. [PubMed]
48. Barclay, A.W.; Brand-Miller, J. The Australian paradox: A substantial decline in sugars intake over the same timeframe that overweight and obesity have increased. Nutrients 2012, 3, 491-504. [CrossRef] [PubMed]
49. Centers for Disease Control and Prevention. Total added sugars, have not resulted in a decrease of obesity or diabetes in the US. Available online: http://www.cdc.gov/diabetes/statistics/slides/maps_diabetesobesity_trends.pdf (accessed on 8 April 2015).
50. Welsh, J.A.; Sharma, A.J.; Grellinger, L.; Vos, M.B. Consumption of added sugars is decreasing in the United States. Am. J. Clin. Nutr. 2011, 94, 726-734. [CrossRef] [PubMed]
51. Marriott, B.; Cole, N.; Lee, E. National estimates of dietary fructose intake increased from 1977 to 2004 in the United States. J. Nutr. 2009, 139, 1228-1235. [CrossRef] [PubMed]
52. Dabfinn, A.; Norat, T.; Romundstad, P.; Vatten, L.J. Dairy products and the risk of type 2 diabetes: A systematic review and dose-response meta-analysis of cohort studies. Am. J. Clin. Nutr. 2013, 98, 1066-1083.